dc.contributor.author | Ferguson, MS | |
dc.contributor.author | Dunmall, LSC | |
dc.contributor.author | Gangeswaran, R | |
dc.contributor.author | Marelli, G | |
dc.contributor.author | Tysome, JR | |
dc.contributor.author | Burns, E | |
dc.contributor.author | Whitehead, MA | |
dc.contributor.author | Aksoy, E | |
dc.contributor.author | Alusi, G | |
dc.contributor.author | Hiley, C | |
dc.contributor.author | Ahmed, J | |
dc.contributor.author | Vanhaesebroeck, B | |
dc.contributor.author | Lemoine, NR | |
dc.contributor.author | Wang, Y | |
dc.date.accessioned | 2020-11-19T09:15:26Z | |
dc.date.available | 2020-02-25 | |
dc.date.available | 2020-11-19T09:15:26Z | |
dc.date.issued | 2020-05-06 | |
dc.identifier.issn | 1525-0016 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68481 | |
dc.format.extent | 1263 - 1275 | |
dc.relation.ispartof | MOLECULAR THERAPY | |
dc.title | Transient Inhibition of PI3K delta Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.ymthe.2020.02.017 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000531081100005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 28 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
qmul.funder | Development of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent::Medical Research Council | en_US |
qmul.funder | Development of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent::Medical Research Council | en_US |